Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Friedreich Ataxia: current status and future prospects.

Katrin Bürk1

  • 1University of Marburg, and Paracelsus-Elena Klinik, Klinikstr. 16, 34128 Kassel, Germany.

Cerebellum & Ataxias
|April 14, 2017
PubMed
Summary

Friedreich ataxia (FA) is an inherited ataxia caused by reduced frataxin protein. This deficiency results in mitochondrial dysfunction and oxidative stress, prompting research into new therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study.

Movement disorders : official journal of the Movement Disorder Society·2023
Same author

The comorbidity and co-medication profile of patients with progressive supranuclear palsy.

Journal of neurology·2023
Same author

Cerebral venous thrombosis, neutropenia and iron-deficiency anemia in Huntington disease.

Neurodegenerative disease management·2021
Same author

Clinical spectrum of the pentanucleotide repeat expansion in the <i>RFC1</i> gene in ataxia syndromes.

Neurology·2020
Same author

Onset features and time to diagnosis in Friedreich's Ataxia.

Orphanet journal of rare diseases·2020
Same author

Aberrant functional connectivity of resting state networks related to misperceptions and intra-individual variability in Parkinson's disease.

NeuroImage. Clinical·2019

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuroscience

Background:

  • Friedreich ataxia (FA) is the most common inherited ataxia.
  • FA is typically caused by GAA expansions in the frataxin gene, leading to reduced frataxin expression.
  • Frataxin deficiency causes mitochondrial iron overload, impaired energy production, and increased reactive oxygen species.

Purpose of the Study:

  • To provide a comprehensive overview of the clinical and genetic aspects of Friedreich ataxia.
  • To discuss current understanding of frataxin biogenesis and function.
  • To explore emerging therapeutic strategies for FA.

Main Methods:

  • Literature review of clinical, genetic, and molecular studies on Friedreich ataxia.
  • Analysis of current research on frataxin protein's role in mitochondrial function.
  • Synthesis of information on novel therapeutic approaches.

Main Results:

  • FA is characterized by specific genetic mutations and distinct clinical manifestations.
  • Frataxin deficiency critically impacts mitochondrial health and cellular processes.
  • Various therapeutic strategies targeting frataxin levels and downstream effects are under investigation.

Conclusions:

  • Understanding FA's genetic basis and frataxin's function is crucial for developing effective treatments.
  • Targeting mitochondrial dysfunction and oxidative stress are key therapeutic goals.
  • Ongoing research holds promise for future interventions in Friedreich ataxia.

Related Experiment Videos